2023 - Reproducibility Studies: Key Questions for IVD Manufacturers When Selecting a Lab Testing Partner
Date2023-06-30
Deadline2023-06-30
VenueWebinar, USA - United States
KeywordsIVD; Diagnostics; Assay Development
Topics/Call fo Papers
When in vitro diagnostic (IVD) manufacturers develop new assays on their instruments, they need to perform reproducibility studies, typically with a minimum of two external lab partners, in order to demonstrate the robustness and reliability of a test and to demonstrate that the test can be reliably performed by other laboratories using the same or similar equipment and methods.
Register for this webinar to learn the key capabilities IVD manufacturers should seek when choosing a trusted lab partner.
Register for this webinar to learn the key capabilities IVD manufacturers should seek when choosing a trusted lab partner.
Other CFPs
- Outsourcing High Potent Oral Solid Dose Late-Stage Development: CDMO Insights
- Revolutionizing Prefilled Injectables through Innovative Technology
- Improving Flexibility & Participant Engagement for Oncology Patients
- How to Increase Patient Engagement in Your Clinical Trials
- Implementation Science: Driving Successful Uptake of Medicines and Medical Innovations in Healthcare Delivery
Last modified: 2023-06-22 01:27:38